Archive: April 2026

INOVIO Announces Proposed Public Offering

Posted on April 1, 2026

INOVIO to Participate in Upcoming Scientific Conference

Posted on April 1, 2026

INOVIO Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Posted on March 12, 2026

INOVIO to Participate in Upcoming Scientific Conferences

Posted on March 9, 2026

INOVIO to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

Posted on March 5, 2026

INOVIO and Akeso Announce Clinical Collaboration to Advance Novel Combination Therapy for Glioblastoma (GBM)

Posted on March 4, 2026

INOVIO to Participate in Upcoming Scientific and Investor Conferences

Posted on February 12, 2026

FDA Accepts for Review INOVIO’s BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)

Posted on December 29, 2025

INOVIO Reports Inducement Grant Under Inducement Plan

Posted on December 19, 2025

INOVIO to Participate in December Investor Conferences

Posted on November 18, 2025

© Copyright 2026 INOVIO Pharmaceuticals. All rights reserved.